The present study has revealed the sustained activation of 4EPB1/eIF4E/Mcl-1 pathway mediated by robust STAT5 activation as a mechanism for the resistance in AML cells with FLT3-ITD. This evidence concerns the gene STAT5A and acute myeloid leukemia.